Tongling Jieya Biologic Technology Co., Ltd.

SZSE:301108 Rapport sur les actions

Capitalisation boursière : CN¥2.2b

Tongling Jieya Biologic Technology Croissance future

Future contrôle des critères 5/6

Tongling Jieya Biologic Technology is forecast to grow earnings and revenue by 55.4% and 23.7% per annum respectively.

Informations clés

55.4%

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Personal Products croissance des bénéfices26.4%
Taux de croissance des recettes23.7%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour22 Apr 2024

Mises à jour récentes de la croissance future

Recent updates

Be Wary Of Tongling Jieya Biologic Technology (SZSE:301108) And Its Returns On Capital

Sep 28
Be Wary Of Tongling Jieya Biologic Technology (SZSE:301108) And Its Returns On Capital

Prévisions de croissance des bénéfices et des revenus

SZSE:301108 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2025825157N/A1961
12/31/2024720134N/A1761
9/30/202458356-1778N/A
6/30/202462877-22121N/A
3/31/202462492-2588N/A
12/31/2023623115-284N/A
9/30/202358810664139N/A
6/30/2023587117169206N/A
3/31/2023614131158185N/A
1/1/2023667141269299N/A
9/30/2022696164232265N/A
6/30/2022717172204238N/A
3/31/2022818185291332N/A
1/1/2022984220128200N/A
9/30/20211,024243187285N/A
6/30/20211,103252179298N/A
3/31/202195622969195N/A
12/31/202074318084188N/A
12/31/20193076878107N/A
12/31/2018312582737N/A
12/31/201724326N/A35N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 301108's forecast earnings growth (55.4% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 301108's earnings (55.4% per year) are forecast to grow faster than the CN market (25.8% per year).

Croissance élevée des bénéfices: 301108's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 301108's revenue (23.7% per year) is forecast to grow faster than the CN market (14% per year).

Croissance élevée des revenus: 301108's revenue (23.7% per year) is forecast to grow faster than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if 301108's Return on Equity is forecast to be high in 3 years time

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y